4D Pharma Joins The SPAC Trend To Fund Its Keytruda-Boosting Biotherapeutic

A Platform To Attract More Investors

 
• By Andrew McConaghie

The Leeds, UK-based company is looking to the alternative route to the US stock market to fund its live biotherapeutics platform.

Nasdaq 2021
The company joins a trend for SPAC biotech mergers which gained momentum last year and has continued into 2021

More from Business

More from Scrip